Related Experiment Video

Updated: Jan 3, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.7K

[Organize the care pathways for hypertensive women during menopause]

Jean-Marc Boivin1, Claire Mounier-Vehier2

  • 1CHRU de Nancy, CIC-P Inserm, 54500 Vandoeuvre-les-Nancy, France; Université de Lorraine, faculté de médecine, département de médecine générale, 54000 Nancy, France.

Presse Medicale (Paris, France : 1983)
|November 16, 2019
PubMed

Insights

Menopause necessitates coordinated screening and care pathways involving multiple physicians. Understanding hormonal factors is crucial for appropriate cardiovascular risk management and prescribing hormone therapies.

Area of Science:

  • Cardiology
  • Gynecology
  • Endocrinology

Background:

  • Menopause is a significant physiological transition with profound effects on women's health.
  • Cardiovascular disease (CVD) risk increases post-menopause due to hormonal changes.

Purpose of the Study:

  • To emphasize the need for integrated care models for menopausal women.
  • To highlight the importance of understanding hormonal specificities in cardiovascular risk assessment.
  • To guide the appropriate prescription of hormone therapies in the menopausal population.

Main Methods:

  • Review of current clinical guidelines and research on menopause management.
  • Analysis of the interplay between hormonal fluctuations and cardiovascular risk factors.
  • Discussion of best practices for physician collaboration in menopausal care.

Main Results:

  • Organized screening and dedicated care pathways are essential for optimal menopausal management.
  • A thorough understanding of hormonal influences on cardiovascular risk is critical.
  • Tailored hormonal treatment prescriptions require careful consideration of individual patient profiles.

Conclusions:

  • Multidisciplinary collaboration among attending physicians, gynecologists-obstetricians, and cardiovascular physicians is vital for comprehensive menopausal care.
  • Addressing the hormonal specificities of cardiovascular risk is paramount for effective prevention and treatment strategies.
  • Informed prescription of hormone therapies, considering individual hormonal profiles, is key to mitigating menopausal health risks.

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.0K

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
690
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
317
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
537
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.7K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
418